eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | hemolytic anemia |
| Comorbidity | C0017920|deficiency of glucose-6-phosphate dehydrogenase |
| Sentences | 1 |
| PubMedID- 25943156 | Primaquine was licenced for anti-relapse therapy in 1952 and became available despite threatening patients having an inborn deficiency of glucose-6-phosphate dehydrogenase (g6pd) with acute haemolytic anaemia. |
Page: 1